A new Medicare demo project will use AI to approve or deny treatments for seniors. The plan is already facing fierce opposition from lawmakers and patient advocates who fear it will lead to dangerous delays and denials of necessary care.
OpenAI is shifting into emergency mode to improve its core ChatGPT product. The move comes as Google’s Gemini 3 model wins praise and user numbers for rival AI services surge.
Apple is changing leadership for its supremely important AI strategy. Veteran John Giannandrea will retire in spring 2026, and former Google and Microsoft AI executive Amar Subramanya is taking over immediately.
OpenAI is reportedly delaying several planned products, including advertising tools and shopping agents, to double down on improving ChatGPT. This comes as competition from Google and Anthropic’s new models increases pressure. Meanwhile, business adoption of generative AI is skyrocketing, with 90% o
The 2026 Forbes 30 Under 30 Media list is out, spotlighting young founders and creators. They’re using AI tools like Krea, building Gen-Z news apps like Newsreel, and redefining authorship and storytelling.
Apple’s head of AI, John Giannandrea, is retiring. He’s being replaced by Amar Subramanya, a former VP of AI at Microsoft. The move signals Apple’s intense focus on catching up in the AI race.
After over 100 years of service, the global copper telephone network is being systematically retired. From the UK to Spain to the US, telecoms are swapping orange cables for fiber and figuring out what to do with thousands of vacant central offices.
Bank of America says Netflix could “kill three birds with one stone” by acquiring Warner Bros. Discovery. The deal, valued over $70 billion, would give Netflix a legendary content library and potentially end the streaming wars for good.
Shopify suffered a significant outage during the peak of Cyber Monday shopping. The company confirmed issues with admin logins and point-of-sale systems, impacting merchants during one of the busiest retail days of the year.
Two new studies point to a specific type of “stemmy” CD8 memory T cell as the critical biomarker for a functional HIV cure. This discovery could lead to treatments that help more people control the virus without daily drugs.
